false
Skip Navigation Links
Education & Events
Clinical Guidelines & Tools
Careers
News & Publications
Advocacy
Membership
About ASNC
Menu
Education & Events
Clinical Guidelines & Tools
Careers
News & Publications
Advocacy
Membership
About ASNC
Hamburger Menu
Catalog
Library
Catalog
Myocardial Perfusion Imaging After CCTA: What Are ...
Myocardial Perfusion Imaging After CCTA: What Are We Looking For?
Faculty
Faculty:
Sharmila Dorbala, MD, MPH, MASNC
Brigham and Women's Hospital
Harvard Medical School
Boston, MA
Disclosures:
Advisory Board- Pfizer, GE Healthcare, Janssen, Eidos; Research Grants-Pfizer, GE Healthcare, Attralus; Speaking Fee-Ionetix
Ron Blankenstein, MD, FASNC
Brigham and Women's Hospital
Harvard Medical School
Boston, MA
Disclosures:
Research Grants – Amgen, Novartis; Consultant – Amgen, Novartis, Silence Therapeutics, Caristo Inc, Star Therapeutics, Roivant Science
Panelists:
Mouaz AL-Mallah, MD, MSc, FASNC
Houston Methodist
Houston, TX
Disclosures:
Research Grant - Siemens; Consultant – Phillips, Jubilant, Pfizer
Dennis Calnon, MD, MASNC
McConnell Heart Hospital at Riverside Methodist Hospital
OhioHealth Heart and Vascular Physician
Columbus, OH
No Disclosures
Randall C. Thompson, MD, MASNC
St. Luke's Mid America Heart Institute
Kansas, City, MO
No Disclosures
Learner Objectives
Upon completion of this module, learner will be able to:
• Discuss the role of myocardial perfusion imaging (MPI) in patients with chest pain in the current multimodality imaging environment
• Provide case-based learning on the appropriate use of MPI across the spectrum of chest pain patients
• Find an optimal pathway to risk-stratify, diagnose and treat chest pain patients.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
×
Myocardial Perfusion Imaging After CCTA: What Are We Looking For? Course List
Login
User Login
Continue with Google
OR
Email
Required
Password
Required
Logging In…
Forgot Password
×
Please select your language
1
English